Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62-8

Eur Urol. 2018 Mar;73(3):e72. doi: 10.1016/j.eururo.2017.10.021. Epub 2017 Nov 4.

¹ Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy. Electronic address: fmassari79@gmail.com.
² Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy.

No abstract available

Publication types